Prevention of progressive joint destruction in adjuvant induced arthritis in rats by a novel matrix metalloproteinase inhibitor, FR217840.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  European Journal of Pharmacology

• Publication date

  2005-01-31

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.EJPHAR.2004.12.014PMID 15680277
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Mammalian collagenase predisposes bone surfaces to osteoclastic resorption

  2004cited by this paper
• Osteoclast Numbers in Lewis Rats with Adjuvant-induced Arthritis: Identification of Preferred Sites and Parameters for Rapid Quantitative Analysis

  2004cited by this paper
• Matrix metalloproteinase-12 (MMP-12) in osteoclasts: new lesson on the involvement of MMPs in bone resorption.

  2004cited by this paper
• Collagenase cleavage of type I collagen is essential for both basal and parathyroid hormone (PTH)/PTH-related peptide receptor-induced osteoclast activation and has differential effects on discrete bone compartments.

  2003cited by this paper
• A microplate assay specific for the enzyme aggrecanase.

  2003cited by this paper
• Assay for Cross-Linked Carboxyterminal Telopeptide of Type I Collagen (ICTP) Unlike CrossLaps Assay Reflects Increased Pathological Degradation of Type I Collagen in Rheumatoid Arthritis

  2003cited by this paper
• Matrix metalloproteinases (MMP) and cathepsin K contribute differently to osteoclastic activities

  2003cited by this paper
• The molecular mechanism of osteoclastogenesis in rheumatoid arthritis

  2002cited by this paper
• A selective inhibitor of matrix metalloproteinases inhibits the migration of isolated osteoclasts by increasing the life span of podosomes

  2002cited by this paper
• Selective matrix metalloproteinase (MMP) inhibition in rheumatoid arthritis - Targetting gelatinase A activation

  2001cited by this paper
• Localisation of matrix metalloproteinases and TIMP-2 in resorbing mouse bone

  2000cited by this paper
• Tumor Necrosis Factor (cid:97) Stimulates Osteoclast Differentiation by a Mechanism Independent of the ODF/RANKL–RANK Interaction

  2000cited by this paper
• Suppression of adjuvant arthritis of rats by a novel matrix metalloproteinase‐inhibitor

  2000cited by this paper
• Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones

  2000cited by this paper
• Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice.

  1999cited by this paper
• Animal models of rheumatoid arthritis.

  1999cited by this paper
• Antiarthritic activity of soluble tumor necrosis factor receptor type I forms in adjuvant arthritis: correlation of plasma levels with efficacy.

  1999cited by this paper
• Recent advances in matrix metalloproteinase inhibitors research.

  1999cited by this paper
• Functional heterogeneity of osteoclasts: matrix metalloproteinases participate in osteoclastic resorption of calvarial bone but not in resorption of long bone

  1999cited by this paper
• The Migration of Purified Osteoclasts Through Collagen Is Inhibited by Matrix Metalloproteinase Inhibitors

  1998cited by this paper
• Ro 32‐3555, an orally active collagenase inhibitor, prevents cartilage breakdown in vitro and in vivo

  1997cited by this paper
• Initiation of Osteoclast Bone Resorption by Interstitial Collagenase*

  1997cited by this paper
• Identification of the membrane-type matrix metalloproteinase MT1-MMP in osteoclasts.

  1997cited by this paper
• Production of collagenase by human osteoblasts and osteoclasts in vivo.

  1996cited by this paper
• A factor derived from polymorphonuclear leukocytes enhances interleukin-1-induced synovial cell collagenase and prostaglandin E2 production in rats.

  1996cited by this paper
• Matrix metalloproteinases are obligatory for the migration of preosteoclasts to the developing marrow cavity of primitive long bones.

  1995cited by this paper
• Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor

  1995cited by this paper
• Localization of matrix metalloproteinase 9 (92-kilodalton gelatinase/type IV collagenase = gelatinase B) in osteoclasts: implications for bone resorption.

  1995cited by this paper
• Identification of matrix metalloproteinase 9 in rabbit osteoclasts.

  1994cited by this paper
• High expression of 92-kD type IV collagenase (gelatinase B) in the osteoclast lineage during mouse development

  1994cited by this paper
• Histomorphometry of periarticular bone in rheumatoid arthritis.

  1994cited by this paper
• Expression of 92 kD type IV collagenase/gelatinase B in human osteoclasts

  1994cited by this paper
• Increased type I collagen degradation correlates with disease severity in rheumatoid arthritis.

  1993cited by this paper
• (Pro)collagenase (matrix metalloproteinase-1) is present in rodent osteoclasts and in the underlying bone-resorbing compartment.

  1993cited by this paper
• Modulation of osteoclast differentiation.

  1992cited by this paper
• Relative roles of collagenase and lysosomal cysteine-proteinases in bone resorption.

  1992cited by this paper
• Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis.

  1985cited by this paper

• Mechanisms of osteoclast activation in inflammatory bone loss in rheumatoid arthritis

  2025cites this paper
• A novel bioavailable curcumin-galactomannan complex modulates the genes responsible for the development of chronic diseases in mice: A RNA sequence analysis.

  2021cites this paper
• Sitagliptin and tofacitinib ameliorate adjuvant induced arthritis via modulating the cross talk between JAK/STAT and TLR-4/NF-κB signaling pathways.

  2020cites this paper
• Antinociceptive and anti-inflammatory effect of sulfated polysaccharide fractions from Sargassum wightii and Halophila ovalis in male Wistar rats

  2016cites this paper
• Targeting TNF-α and NF-κB Activation by Bee Venom: Role in Suppressing Adjuvant Induced Arthritis and Methotrexate Hepatotoxicity in Rats

  2013cites this paper
• Antinociceptive and Anti-Inflammatory Activities of Sargassum wightii and Halophila ovalis Sulfated Polysaccharides in Experimental Animal Models

  2013cites this paper
• Involvement of 15‐lipoxygenase in the inflammatory arthritis

  2012cites this paper
• Anti-inflammatory and antioxidant potential of alginic acid isolated from the marine algae, Sargassum wightii on adjuvant-induced arthritic rats

  2012cites this paper
• N-O-isopropyl sulfonamido-based hydroxamates: kinetic characterisation of a series of MMP-12/MMP-13 dual target inhibitors.

  2012cites this paper
• New hope for the treatment of osteoarthritis through selective inhibition of MMP-13.

  2011influential citation
• Prostaglandin D2 inhibits interleukin-1β-induced matrix metalloproteinase-1 and -13 production by human osteoarthritic chondrocytes

  2011cites this paper
• Orally active MMP-1 sparing α-tetrahydropyranyl and α-piperidinyl sulfone matrix metalloproteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease.

  2010cites this paper
• Proteinases involved in matrix turnover during cartilage and bone breakdown

  2009cites this paper
• N-O-isopropyl sulfonamido-based hydroxamates: design, synthesis and biological evaluation of selective matrix metalloproteinase-13 inhibitors as potential therapeutic agents for osteoarthritis.

  2009cites this paper
• Effects of Inflammatory Mediators on Matrix Metalloproteinase-2 Expression by Rheumatoid Arthritis Synovial Fibroblasts

  2009cites this paper
• Anti-inflammatory and ethopharmacological effects of an ethanolic leaf extract of Palisota Hirsuta K. Schum. (Commelinaceae)

  2009cites this paper
• Effect of the oral application of a highly selective MMP-13 inhibitor in three different animal models of rheumatoid arthritis

  2009cites this paper
• Metalloproteases as potential therapeutic targets in arthritis treatment

  2008cites this paper
• Inhibition of interleukin-1beta-induced matrix metalloproteinases 1 and 13 production in human osteoarthritic chondrocytes by prostaglandin D2.

  2008cites this paper
• Zea mays L. variedad morada y su efecto protector de daño osteoarticular en artritis inducida en ratas

  2008cites this paper
• Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.

  2006cites this paper
• Negative Regulation of Osteoclastogenesis by Ectodomain Shedding of Receptor Activator of NF-κB Ligand*

  2006cites this paper
• Direct modulation of rheumatoid inflammatory mediator expression in retinoblastoma protein-dependent and -independent pathways by cyclin-dependent kinase 4/6.

  2006cites this paper
• Macrophage migration inhibitory factor: a mediator of matrix metalloproteinase-2 production in rheumatoid arthritis

  2006cites this paper
• Understanding the role of tissue degrading enzymes and their inhibitors in development and disease.

  2006cites this paper
• Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice.

  2006cites this paper
• Negative regulation of osteoclastogenesis by ectodomain shedding of receptor activator of NF-kappaB ligand.

  2006cites this paper
• Prevention of arthritic inflammation using an oriental herbal combination BDX-1 isolated fromAchyranthes bidentata andAtractylodes japonica

  2005cites this paper
• MAP Kinase activation is required for the MMP-9 induction by TNF-stimulation

  2005cites this paper
• Extended Report

  year unknowncites this paper